Share your research with the global pathology community. We welcome original research, clinical cases, AI studies, reviews and expert commentary.
We combine rigorous peer review with global accessibility, ensuring your research reaches the widest possible audience of pathologists, laboratory scientists, and clinical researchers.
Every submission undergoes double-blind peer review by at least two qualified reviewers with subject-matter expertise. Our reviewer pool includes over 200 active pathologists and researchers across 40 countries, ensuring diverse perspectives and thorough evaluation of scientific merit, methodology, and clinical relevance. Average time from submission to first decision is 28 days.
Your published work is accessible to over 12,000 registered professionals in 78 countries. Our readership includes consultant pathologists, laboratory directors, trainees, biomedical scientists, and computational researchers. Articles published in GPP are read across Europe, the Middle East, South Asia, Sub-Saharan Africa, and the Asia-Pacific region, giving your research genuine international visibility.
All articles are published under a Creative Commons CC BY 4.0 licence, making your work freely available to read, download, share, and build upon without subscription barriers. Open access publication ensures that researchers at institutions with limited library budgets can access and cite your work, maximising its impact and reach across the global pathology community.
Every published article receives a unique Digital Object Identifier (DOI) registered through Crossref, providing a permanent, citable link to your work. DOI assignment ensures your article is discoverable through standard academic search tools and can be reliably referenced in future publications, grant applications, and tenure portfolios. DOIs are assigned upon acceptance and remain active indefinitely.
Published articles are indexed in Google Scholar, DOAJ (Directory of Open Access Journals), Crossref, Semantic Scholar, and institutional repository networks. We are actively pursuing indexing in PubMed Central, Scopus, and Web of Science. Full metadata is deposited with each indexing service to maximise discoverability through both academic and general search engines.
Every article includes real-time citation tracking through Google Scholar and Crossref Cited-by counts, along with Altmetric attention scores that capture mentions on social media, news outlets, policy documents, and educational platforms. Authors receive quarterly reports on their article's performance, including download counts, geographic distribution of readers, and citation growth.
We accept submissions across six primary article types. Each type has specific structural requirements, word limits, and formatting expectations detailed below.
Novel findings from laboratory investigations, clinical studies, digital pathology implementations, or computational pathology research. Must include original data, statistical analysis where appropriate, and conclusions supported by the evidence presented.
Word limit: 4,000 – 6,000 words (excluding references and figure legends)
Structure: Title, Abstract (structured, 250 words max), Introduction, Materials & Methods, Results, Discussion, Conclusion, References
Figures/Tables: Up to 8 figures and 5 tables
References: 30 – 60 references recommended
Rare, unusual, or diagnostically instructive cases with anonymised clinical details, high-quality histopathological images, and a focused discussion of the differential diagnosis and clinical significance. All case reports must include documented patient consent or ethics committee waiver.
Word limit: 1,500 – 2,500 words (excluding references and figure legends)
Structure: Title, Abstract (unstructured, 150 words max), Introduction, Case Presentation, Discussion, Conclusion, References
Figures/Tables: Up to 6 figures and 2 tables
References: 15 – 25 references recommended
Comprehensive, authoritative reviews of current knowledge in a pathology subspecialty, diagnostic technique, or technology area. Reviews should synthesise existing literature, identify gaps in knowledge, and provide a balanced assessment of the current state of the field. Systematic reviews must follow PRISMA guidelines.
Word limit: 5,000 – 8,000 words (excluding references and figure legends)
Structure: Title, Abstract (structured, 300 words max), Introduction, Methods (for systematic reviews), Body Sections, Discussion, Conclusion, References
Figures/Tables: Up to 10 figures and 6 tables
References: 60 – 150 references recommended
Concise reports of preliminary findings, novel techniques, or observations that merit rapid dissemination but do not require the full structure of an original research article. Short communications undergo the same peer review process as full-length articles.
Word limit: 1,000 – 2,000 words (excluding references and figure legends)
Structure: Title, Abstract (unstructured, 100 words max), Body (no required subheadings), References
Figures/Tables: Up to 3 figures and 2 tables
References: 10 – 20 references recommended
Scholarly correspondence commenting on recently published articles, raising points of scientific debate, or presenting very brief observations relevant to the pathology community. Letters may be accompanied by a response from the original authors at the editor's discretion.
Word limit: 500 – 1,000 words
Structure: No required subheadings; continuous prose
Figures/Tables: Up to 1 figure and 1 table
References: 5 – 10 references recommended
Detailed descriptions of new laboratory techniques, staining protocols, digital pathology workflows, AI model validation methodologies, or equipment optimisation procedures. Technical notes should be sufficiently detailed for readers to reproduce the described method in their own laboratory.
Word limit: 1,500 – 3,000 words (excluding references and figure legends)
Structure: Title, Abstract (unstructured, 150 words max), Introduction, Protocol/Method, Results/Validation, Discussion, References
Figures/Tables: Up to 5 figures and 3 tables
References: 10 – 25 references recommended
Our editorial process is designed to be transparent, efficient, and supportive. Most articles progress from submission to publication within 8 – 14 weeks.
Format your manuscript according to the article type requirements listed above. Use our downloadable Word or LaTeX template to ensure compliance with formatting standards. Include all required sections: title page with author details and ORCID identifiers, structured abstract, main text following IMRAD structure (for research articles), references in Vancouver style, figure legends, and all required disclosures (conflicts of interest, funding sources, ethics approval, patient consent). Prepare figures as separate high-resolution files (minimum 300 DPI for photographs, 600 DPI for line art) in TIFF, PNG, or EPS format.
Upload your manuscript through our secure online submission portal. You will be asked to provide: the manuscript file (Word or LaTeX), all figures as separate files, a cover letter addressed to the Editor-in-Chief explaining the significance of your work, completed conflict of interest declarations for all authors, and a suggested list of three potential reviewers (with email addresses and institutional affiliations). The corresponding author must have a registered GPP account. Typical upload time is 10 – 15 minutes. You will receive an automated confirmation email with your manuscript tracking number within one hour of submission.
Your manuscript undergoes double-blind peer review: neither the authors nor the reviewers know each other's identities. The editorial office selects two or three reviewers with demonstrated expertise in your article's subject area, drawn from our pool of over 200 active reviewers across 40 countries. Reviewers are asked to evaluate: originality and novelty of findings, scientific rigour and methodological soundness, appropriateness of statistical analysis, clinical relevance and significance, quality and relevance of figures and tables, and completeness of the literature review. Reviewers are given 21 days to return their reports. If a reviewer does not respond within 14 days, an alternate is assigned. Average time from submission to first peer review decision is 28 days.
Based on reviewer comments, the editorial team will issue one of four decisions: Accept as submitted (rare on first review), Minor revisions required, Major revisions required, or Reject. If revisions are requested, you will receive a detailed decision letter summarising the reviewers' comments and the editor's recommendations. Authors are given 30 days to submit revised manuscripts for minor revisions and 60 days for major revisions. Your revised submission must include a point-by-point response letter addressing each reviewer comment, with clear references to the specific changes made in the manuscript. Extensions may be granted upon request.
Once revisions are satisfactory, the Editor-in-Chief issues a formal acceptance letter. Revised manuscripts may be sent back to the original reviewers for a second evaluation if major changes were requested. Upon acceptance, you will be asked to: sign the copyright transfer agreement (or confirm Creative Commons licence selection), submit final high-resolution figures, confirm the accuracy of all author names, affiliations, and ORCID identifiers, and arrange payment of any applicable article processing charges. The editorial office will prepare your article for production, including copyediting, typesetting, and XML markup for indexing.
Your article is published online within 5 – 10 working days of acceptance. You will receive page proofs for review before final publication. Each article is assigned a unique DOI, registered with Crossref, and deposited with all indexing services (Google Scholar, DOAJ, Semantic Scholar). The article is linked to your GPP author profile, where it appears alongside your other publications, citation metrics, and professional credentials. You will receive a notification when the article goes live, along with a shareable link and social media assets for promoting your work.
All manuscripts must adhere to the following formatting requirements. Submissions that do not comply will be returned to the author for reformatting before entering peer review.
Original research articles must follow the IMRAD format: Introduction (state the objective and rationale), Materials and Methods (describe study design, subjects, techniques, and statistical methods), Results (present findings without interpretation), and Discussion (interpret results in context of existing literature, acknowledge limitations, and state conclusions). Review articles may use thematic subheadings. Case reports follow the structure: Introduction, Case Presentation, Discussion, Conclusion.
References must be formatted according to the Vancouver (ICMJE) citation style. Number references consecutively in the order they first appear in the text using superscript Arabic numerals. List all authors when there are six or fewer; for seven or more, list the first six followed by "et al." Journal titles should be abbreviated according to the NLM catalogue. Include DOIs for all references where available. We recommend using reference management software (EndNote, Zotero, or Mendeley) with the Vancouver output style.
Figures must be submitted as separate files in TIFF, PNG, or EPS format. Minimum resolution: 300 DPI for halftone/photographic images, 600 DPI for line art, 400 DPI for combination figures. Maximum file size per figure: 20 MB. Colour figures are published at no additional cost. All figures must include descriptive legends. Tables should be created using the Word table function (not embedded images) and placed at the end of the manuscript file. All tables must have a title and explanatory footnotes where necessary. Histopathological images must include magnification and stain information in the legend.
All research involving human subjects must have received approval from an institutional review board (IRB) or research ethics committee, in accordance with the Declaration of Helsinki (2013 revision). The ethics approval number and name of the approving committee must be stated in the Methods section. Animal studies must comply with ARRIVE guidelines. Authors must declare whether informed consent was obtained from study participants. Case reports require documented patient consent or an ethics committee waiver for consent. Ethics approval documentation may be requested during the review process.
All authors must disclose any financial or non-financial conflicts of interest that could be perceived as influencing the research or its interpretation. This includes: funding sources for the research, employment relationships, consultancy fees, honoraria, stock ownership, patents, and paid expert testimony. If no conflicts exist, a statement of "The authors declare no conflicts of interest" must be included. The corresponding author is responsible for ensuring that all co-authors have disclosed their conflicts. Failure to declare known conflicts may result in retraction.
The corresponding author must provide a valid ORCID identifier at the time of submission. We strongly encourage all co-authors to also provide their ORCID identifiers. ORCID (Open Researcher and Contributor ID) provides a persistent digital identifier that distinguishes you from other researchers and ensures your work is accurately attributed. If you do not have an ORCID, you can register for free at orcid.org. ORCID identifiers are displayed on the published article and deposited with Crossref to improve discoverability and citation accuracy.
We are committed to fair, thorough, and constructive peer review. Our process is designed to improve the quality of published research while respecting the time and effort of both authors and reviewers.
Reviewers are selected based on their published expertise in the manuscript's subject area, geographic diversity, and absence of conflicts of interest with the authors or their institutions. Our editorial team maintains a database of over 200 active reviewers across 40 countries. Reviewers must hold at least a doctoral degree or equivalent professional qualification and have a demonstrable track record of published research in pathology or a related discipline. Authors may suggest potential reviewers, and these suggestions are considered but not guaranteed.
Reviewers evaluate manuscripts against the following criteria: originality and novelty of the research question; scientific rigour and reproducibility of methods; appropriateness and correctness of statistical analyses; quality, clarity, and relevance of figures and tables; completeness of the literature review; clinical significance and practical implications; clarity and quality of written English; and adherence to ethical standards. Reviewers provide both a structured scorecard and free-text comments, including confidential remarks visible only to the editor.
Reviewers are given 21 days to return their reports. The editorial team monitors review progress and sends reminders at day 14. If a reviewer has not responded by day 21, an alternate reviewer is assigned. Average time from submission to first editorial decision is 28 days. Possible decisions are: Accept, Minor Revisions, Major Revisions, Revise and Resubmit, or Reject. Authors may appeal a rejection decision by writing to the Editor-in-Chief within 30 days, providing a detailed rebuttal with supporting evidence.
Global Pathology Publications adheres to the principles established by the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE).
All submitted manuscripts are screened for plagiarism using industry-standard similarity detection software before entering peer review. A similarity index above 15% (excluding references, methods sections describing standard techniques, and properly attributed quotations) will trigger a manual review. Manuscripts with substantial unattributed overlap with previously published work will be rejected. Self-plagiarism (text recycling from the author's own previously published work) is also screened and must be disclosed in the cover letter. If plagiarism is detected after publication, the article will be retracted in accordance with COPE guidelines, and the authors' institutions will be notified.
Manuscripts submitted to Global Pathology Publications must not be simultaneously under consideration by any other journal. Authors must confirm at the time of submission that the manuscript has not been published previously (in whole or in part) and is not currently under review elsewhere. Submission of a manuscript implies that all authors have approved the submission and that, if accepted, the article will not be published elsewhere in the same form without the written consent of the publisher. Preprint deposits (e.g., on medRxiv or bioRxiv) are permitted and should be declared in the cover letter.
Authorship must be based on the four ICMJE criteria: (1) substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data; (2) drafting the work or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work. All individuals who meet these four criteria must be listed as authors. Individuals who contributed but do not meet all four criteria should be acknowledged in the Acknowledgements section. Ghost authorship, gift authorship, and undisclosed use of writing services are violations of our authorship policy.
Authors are encouraged to make the data underlying their research findings available whenever ethically and legally permissible. Data availability statements must be included in all original research articles and systematic reviews. Acceptable approaches include: depositing data in a public repository (e.g., Zenodo, Figshare, or Dryad) and providing the DOI or accession number; making data available upon reasonable request to the corresponding author; or providing supplementary data files alongside the published article. If data cannot be shared due to patient privacy, legal restrictions, or proprietary constraints, the reasons must be clearly stated in the data availability statement.
To sustain open access publishing and cover the costs of peer review coordination, copyediting, typesetting, DOI registration, and long-term digital archiving, we charge an article processing charge (APC) upon acceptance. APCs vary by article type: Original Research and Review Articles incur a standard APC, while Case Reports, Short Communications, Letters, and Technical Notes are charged at a reduced rate. Exact fees are listed on the submission portal and confirmed before the author commits to publication. No charges are levied for rejected manuscripts.
We believe that financial constraints should not prevent the dissemination of valuable research. Full or partial APC waivers are available for: authors from low- and lower-middle-income countries (as classified by the World Bank); early-career researchers within five years of completing their terminal degree; authors without institutional funding for publication costs; and invited review articles. Waiver requests are evaluated on a case-by-case basis and do not influence editorial decisions. To apply, select the waiver option during submission and provide a brief justification.
All articles published in Global Pathology Publications are immediately and permanently available under a Creative Commons Attribution 4.0 International (CC BY 4.0) licence. This means anyone may read, download, copy, distribute, print, search, or link to the full text of the article, or use it for any other lawful purpose, without asking prior permission from the publisher or the author, provided the original work is properly cited. We do not impose embargo periods, and there are no subscription barriers for readers. Institutional agreements for bulk APC discounts are available upon request.
Google Scholar, DOAJ (Directory of Open Access Journals), Crossref, Semantic Scholar, BASE (Bielefeld Academic Search Engine), OpenAIRE, CORE, and institutional repository harvesting via OAI-PMH protocol.
PubMed Central (PMC), Scopus, Web of Science (Emerging Sources Citation Index), Embase, and African Journals Online (AJOL). Applications are under review and updates are posted on this page as decisions are received.
Each article displays Crossref Cited-by counts, Google Scholar citation data, and Altmetric attention scores tracking mentions across social media, news outlets, policy documents, Wikipedia, and educational syllabi. Authors receive quarterly performance reports.
A. Patel, R. Johansson, M. Ibrahim, S. Chen, K. O'Brien
L. Fernandez, T. Nakamura, D. Osei-Mensah
S. Kulkarni, E. van der Berg, P. Martins, A. Zhao
J. Thompson, H. Al-Rashid, N. Okonkwo
F. Mbeki, C. Okafor, R. Sharma, B. Mensah